eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cardiomyopathy |
| Comorbidity | C0011860|type 2 diabetes |
| Sentences | 8 |
| PubMedID- PMC4328436 | These imaging markers show promise for the detection of pre-clinical cardiomyopathy in patients with type 2 diabetes. |
| PubMedID- 21283592 | Conclusions: our findings indicate that hyperglycemia is a causal factor for increased levels of pro-inflammatory cytokine mif which plays a role in the development of cardiomyopathy occurring in patients with type 2 diabetes. |
| PubMedID- 20414371 | To date, the mcp-1 –2518 a>g polymorphism has been associated with coronary artery disease, nonfamilial idiopathic dilated cardiomyopathy, carotid atherosclerosis in patients with type 2 diabetes, myocardial infarction, ischemic heart disease, and hypertension [33–38]. |
| PubMedID- 26317014 | Atherosclerosis and cardiomyopathy in type 2 diabetes are caused in part by pathway-selective insulin resistance, which increases mitochondrial ros production from free fatty acids, and by inactivation of antiatherosclerosis enzymes by ros. |
| PubMedID- 21030723 | Atherosclerosis and cardiomyopathy in type 2 diabetes are caused in part by pathway-selective insulin resistance, which increases mitochondrial ros production from free fatty acids and by inactivation of antiatherosclerosis enzymes by ros. |
| PubMedID- 20467928 | This review focuses on the mechanistic approach to understand the molecular basis of diabetic cardiomyopathy in patients with type 2 diabetes mellitus. |
| PubMedID- 24389129 | Ang 1-7 represents a promising therapy for diabetic cardiomyopathy associated with type 2 diabetes mellitus. |
| PubMedID- 22166644 | Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus. |
Page: 1